Dr. Reddy's Laboratories Ltd. closed 18.05% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr. Reddy's Laboratories Ltd. closed 16.87% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy's Laboratories, USA, a wholly owned subsidiary of the company, has successfully completed the sale of all issued ...

Natixis Advisors LLC increased its position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 422.7% in the 4th quarter, according to the company in its most recent filing with ...

Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of biosimilars, and Dr Reddy’s Laboratories SA, a wholly-owned subsidiary of Dr Reddy’s Laboratories ...

Guangzhou, China-based commercial-stage biopharmaceutical firm Bio-Thera Solutions and Hyderabad-based Dr. Reddy’s Laboratories, through one of its subsidiaries, signed commercialisation and ...

Dr. Reddy's Laboratories is among India’s leading pharmaceutical companies. The company is primarily known for manufacturing active pharmaceutical ingredients (APIs). Dr. Reddy's Laboratories ...

HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

31 May, 2006 28 Aug, 2006 1:1 For every 1 share held; Holder will receive 1 bonus shares. 24 Mar, 1994 08 Apr, 1994 2:1 For every 1 share held; Holder will receive 2 bonus shares. 30 Sep, 1992 04 ...